Methylene Blue for Mood

By Reviv Health Editorial TeamUpdated October 19, 2026

Methylene blue is studied for mood mainly because it inhibits monoamine oxidase A (MAO-A) — an enzyme that breaks down serotonin, norepinephrine and dopamine — which may leave more of these neurotransmitters available. The same action is why it can cause serotonin syndrome when combined with antidepressants. It's a small molecule with a surprisingly long psychiatric history, and that history is worth understanding before you add it to any protocol.

Methylene blue started life as a textile dye in 1876 — and that origin story still shapes how many people misunderstand it. Scientists quickly discovered its potential in medicine: it became one of the earliest drugs used to treat malaria, and later found its primary clinical role as a treatment for methemoglobinemia, a rare blood disorder in which hemoglobin can't carry oxygen to tissues. What's less widely known is that methylene blue has a documented history in psychiatry, where researchers have explored its use in mood disorders including depression and bipolar disorder since the early 20th century. That history makes it one of the most unusual compounds at the intersection of pharmaceutical medicine and modern brain health supplementation. At Reviv Health, we believe understanding a compound's full history makes you a smarter, safer user.

This article covers how methylene blue may support mood and emotional wellbeing, what the research says about its effects on serotonin, dopamine, and brain energy, and what the important safety cautions are. You'll also learn why its antidepressant potential genuinely excites researchers — and why that excitement doesn't mean you can skip medical guidance.

Does Methylene Blue Improve Mood?

Methylene blue may improve mood through at least two distinct mechanisms — and understanding both helps you weigh the evidence clearly. The first is its action as a monoamine oxidase inhibitor, a class of compounds that slow the breakdown of neurotransmitters including serotonin, dopamine, and norepinephrine. This is the same fundamental pathway targeted by older antidepressant classes known as MAOIs. By acting as an inhibitor of this enzyme, methylene blue could increase the availability of these mood-regulating neurotransmitters in the synapse.

The second mechanism involves mitochondrial support. Brain cells are among the most metabolically demanding cells in the body, and depressive disorders are increasingly linked to mitochondrial dysfunction and reduced cellular energy production. Methylene blue works inside the mitochondria, acting as an alternative electron carrier that helps maintain ATP production even when the electron transport chain's normal complexes are compromised. The hypothesis is that a better energy supply could support more stable mood regulation — an idea that is still being tested.

Clinical research here has a surprisingly long history. In the 1980s, small trials by Naylor and colleagues in the UK reported less depression in people with bipolar disorder taking 300 mg/day of methylene blue than 15 mg/day, and a 2017 randomised crossover trial found similar effects at 195 mg/day (details below). By contrast, a 2016 single-dose study in healthy adults, published in Radiology, found a small improvement in memory retrieval but no significant change in mood scores (Rodriguez et al., 2016). At Reviv Health, we only source pharmaceutical-grade methylene blue precisely because the dose precision this research demands isn't possible with industrial-grade stain products.

How Does Methylene Blue Affect Serotonin?

Methylene blue affects serotonin primarily by acting as a monoamine oxidase inhibitor — that's the mechanism researchers keep coming back to. Monoamine oxidase is the enzyme responsible for breaking down serotonin after it's released at synapses. When MAO activity is inhibited, serotonin persists longer in the synaptic cleft, producing effects similar to what SSRIs achieve through a different route. This shared outcome — increased serotonin signaling — is why researchers have explored methylene blue as a potential antidepressant compound for decades.

Modern research on methylene blue and mood began in the early 1980s. In 1983, Narsapur and Naylor reported an uncontrolled series in which 14 of 19 people with manic-depressive illness who hadn't responded to standard treatments were judged to improve on oral methylene blue (Narsapur SL & Naylor GJ, 1983, Journal of Affective Disorders). A follow-up 2-year double-blind crossover trial in 31 lithium-treated patients found less depression on 300 mg/day than on 15 mg/day, though only 17 completed it and the authors questioned whether 15 mg/day was a true placebo (Naylor GJ et al., 1986, Biological Psychiatry).

That same mechanism also creates a real safety concern you can't ignore. Methylene blue may interact dangerously with serotonergic medications. Taking it alongside SSRIs, SNRIs, tricyclic antidepressants, or other MAO inhibitors can trigger serotonin syndrome — a potentially life-threatening excess of serotonin activity. Symptoms include agitation, rapid heart rate, hyperthermia, and in severe cases, seizures. This risk is well documented: the FDA issued safety communications in 2011, and the current prescription label carries a boxed warning against combining methylene blue with SSRIs, SNRIs, MAOIs and opioids.

Methylene blue is a potent MAO-A inhibitor in laboratory tests (Ramsay et al., 2007). Reported serotonin syndrome cases mostly involved intravenous doses of 1–8 mg/kg in people taking serotonergic antidepressants, but the FDA has said it isn't known whether lower doses or oral use are safe alongside these drugs — so no dose is known to be safe in combination. The dose-response relationship matters: the same property that may produce mood benefits at low doses can become dangerous at higher doses or when combined with certain antidepressants. Low dose use with careful attention to drug interactions isn't just a recommendation — it's the foundation of any responsible methylene blue mood protocol. At Reviv Health, we don't recommend combining MB with any prescription antidepressant without explicit physician sign-off.

Is Methylene Blue Good for Depression?

Methylene blue has shown some promise for depressive symptoms in small trials, but the evidence isn't sufficient for it to be recommended as a treatment. Interest in methylene blue in the treatment of mood disorders has existed for over a century — that's not hype, it's documented history. Large-scale randomized controlled trials specifically targeting major depressive disorder are still limited, though.

What existing research does suggest is that methylene blue, at prescription-level doses under psychiatric supervision, can reduce depressive symptoms in specific contexts. In a 2017 double-blind crossover trial in 37 people with bipolar disorder who were already taking lamotrigine, 195 mg/day improved residual depression and anxiety compared with a 15 mg/day 'placebo' dose, with no significant effect on cognition (Alda M et al., 2017, British Journal of Psychiatry). Researchers are studying it as an adjunct treatment, meaning it's used to treat depression alongside established therapies rather than as a replacement. That's a meaningful distinction.

The neuroprotective properties documented in animal models are also relevant here. Methylene blue reduces oxidative stress in brain regions associated with mood regulation, supports mitochondrial efficiency in prefrontal neurons, and enhances cytochrome c oxidase activity in areas known to show reduced activity in depressive states. These cellular mechanisms are exactly why practitioners and researchers view methylene blue as a legitimate candidate for further study in neuropsychiatric disorders.

Anyone using methylene blue with depression in mind needs to be clear-eyed about what it is. It isn't an FDA-approved antidepressant. It's a compound with antidepressant mechanisms that some practitioners include in integrative mental health protocols — always alongside professional oversight, and never combined with conventional antidepressants without medical supervision due to serotonin syndrome risk. At Reviv Health, we're transparent about where the science is strong and where it's still developing.

Can Methylene Blue Help with Seasonal Mood Changes?

Seasonal mood changes are linked to reduced light exposure, disrupted circadian rhythms, and downstream effects on serotonin and dopamine — and that's where methylene blue's dual action becomes theoretically interesting. Light therapy is the most well-established first-line intervention. Some practitioners combine it with other approaches that support neurotransmitter balance and brain energy, and methylene blue's action on serotonin via MAO inhibition plus its cellular energy support via mitochondrial pathways makes it a plausible complement.

In practice, some integrative health providers suggest low-dose methylene blue as a complementary tool during winter months for people who experience seasonal mood dips without a clinical SAD diagnosis. The rationale is straightforward: seasonal mood changes are associated with reduced brain serotonin activity and lower neuronal energy efficiency, and methylene blue may in theory address both — but there are no published clinical trials of methylene blue for seasonal mood changes. It doesn't replace light therapy or pharmaceutical treatment of diagnosed seasonal affective disorder. At Reviv Health, we always recommend pairing methylene blue with evidence-based lifestyle interventions rather than using it as a standalone fix.

Long-term use for mood support requires the same cautions that apply generally: pharmaceutical grade product only, low doses, no concurrent serotonergic medications, and ongoing awareness of how your body responds. If you're under the care of a psychiatrist or physician for a mood disorder, methylene blue should only be introduced with that professional's knowledge.

The Mitochondrial Connection to Mood

One of the most important developments in brain health research over the last two decades is the recognition that mitochondrial function is central to mood regulation — not just energy levels. Neurons in the prefrontal cortex and limbic system are especially dependent on reliable mitochondrial ATP production. When mitochondrial efficiency drops, these regions underperform, contributing to the cognitive slowing, emotional blunting, and fatigue that characterize both depression and brain fog. On this view, mitochondrial dysfunction may be one contributor to depression rather than just a side effect of it — a hypothesis that is still being tested.

Methylene blue is a synthetic blue dye that has been widely studied as a mitochondrial support compound in laboratory research. It acts at the electron transport chain, enhancing cytochrome c oxidase activity and helping cells maintain energy output under oxidative stress. Because it crosses the blood-brain barrier efficiently, its mitochondrial effects are particularly pronounced in neural tissue. Methylene blue could, according to the mitochondrial theory of depression, directly address one of the root physiological causes of depressed mood — and that's a genuinely exciting hypothesis for researchers. At Reviv Health, we track this research closely because cellular energy is one of the most underrated pillars of mental wellness.

Laboratory and animal research on dementia has found that methylene blue can reduce tau protein aggregation and support neuronal function in aging brain cells, although clinical trials of a methylene blue-derived drug in Alzheimer's have not met their primary goals. These findings across multiple research programs make it one of the more scientifically interesting compounds in the brain health and cognitive function space.

Safety and Cautions for Mood Applications

The safety profile of low-dose methylene blue is generally favorable for healthy adults who aren't on serotonergic medications — but the cautions are non-negotiable. Here's what you need to know about methylene blue before using it for mood:

Don't take methylene blue alongside SSRIs, SNRIs, tricyclic antidepressants, MAO inhibitors or other serotonergic drugs; the prescription label also warns against opioids. Serotonin syndrome risk is real and can be fatal. See methylene blue drug interactions for more detail.
Use only pharmaceutical grade or USP grade methylene blue. Industrial or dye-grade products — the kind used as a biological stain in labs — contain contaminants that negate any potential benefit and introduce new risks.
Keep doses low. No dose of methylene blue has been established for mood support in healthy people. The mood trials used 195–300 mg/day of pharmaceutical methylene blue under psychiatric supervision; higher doses carry greater risk of side effects and interactions.
Don't use it as a substitute for professional treatment of diagnosed depression or bipolar disorder. Methylene blue is best understood as a complement to appropriate care, not a replacement.
People with G6PD deficiency should avoid methylene blue entirely — it can cause hemolytic anemia.
Avoid methylene blue during pregnancy and while breastfeeding. Its prescription label warns it may cause fetal harm and advises stopping breastfeeding during and for up to 8 days after treatment.

Methylene blue's use for mood and mental health represents an area where promising mechanisms meet an incomplete clinical evidence base — and that's exactly how you should treat it. Bring genuine interest in the science, humility about what's still being studied, and appropriate professional oversight to any protocol you consider. At Reviv Health, we believe those three things together are what responsible supplementation looks like.

Methylene blue for mood questions

Can methylene blue replace antidepressants?

No — methylene blue isn't a replacement for prescribed antidepressant medications, and the two shouldn't be combined without physician guidance due to serotonin syndrome risk. It may serve as a useful adjunct in integrative protocols under medical supervision, but the evidence base for its use as a standalone antidepressant treatment in clinical depression doesn't yet support that role definitively. Your prescribing physician needs to be part of that conversation.

How quickly does methylene blue affect mood?

Some users report subtle mood improvements within days of consistent low-dose use. The timeline likely reflects both the acute MAO inhibitor effects on serotonin and the more gradual mitochondrial improvements in neuronal energy production. Controlled trials have measured mood over weeks to years, so there's no reliable evidence on whether it acts faster than conventional antidepressants. That said, individual responses vary considerably.

Is methylene blue used in psychiatry?

Yes, historically and to a limited extent currently. Methylene blue has been a subject of interest to psychiatrists since the early 20th century. It was studied in controlled trials for use in the treatment of depression and bipolar disorder, and interest in the use of methylene blue in neuropsychiatric disorders continues in research settings today. It isn't a mainstream psychiatric treatment, but it occupies a recognized research niche that's worth watching.

What is the difference between methylene blue and SSRIs for mood?

SSRIs block the reabsorption of serotonin at the synapse, keeping it available longer. Methylene blue can raise serotonin levels by a different route — it inhibits the MAO enzyme that breaks serotonin down. Both approaches increase serotonin signaling, but through different mechanisms. Methylene blue also has mitochondrial and antioxidant effects in laboratory studies, while SSRIs have a much larger clinical evidence base for treating depression. The two mechanisms combined can produce dangerous serotonin excess, which is why combining them is contraindicated.

Can people with bipolar disorder use methylene blue?

Small trials in bipolar disorder have shown some positive results for depressive symptoms — most recently a 2017 randomised crossover trial in which methylene blue was added to lamotrigine (Alda et al.). Those trials used 195–300 mg/day under psychiatric supervision, not low supplement doses. Bipolar disorder is a complex condition requiring professional management, though, and any use of methylene blue in this context should be discussed with a psychiatrist. The interaction risk with medications commonly used for bipolar disorder makes independent self-experimentation particularly inadvisable here. Don't go it alone.